Connection

MARK ZOBECK to Risk Factors

This is a "connection" page, showing publications MARK ZOBECK has written about Risk Factors.
Connection Strength

0.179
  1. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy. 2023 03; 43(3):205-214.
    View in: PubMed
    Score: 0.072
  2. Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene. Pediatr Blood Cancer. 2021 08; 68(8):e29036.
    View in: PubMed
    Score: 0.063
  3. Predicting development of pediatric chronic immune thrombocytopenia at disease onset using a statistical risk model. Blood. 2026 Apr 16; 147(16):1863-1872.
    View in: PubMed
    Score: 0.022
  4. Incidence of Cancers Among Children Living With HIV in Malawi After Widespread Availability of Antiretroviral Therapy: A Population-Based Study. JCO Glob Oncol. 2026 Mar; 12(3):e2500448.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.